In addition, some problems remain unclear, and the detailed mechanisms need to be further studied, including how Aβ in exogenous blood affects the recipients, whether tau causes AD pathology through blood transfusion, and what the association is between different frequencies, components, and volumes of blood transfusion and the risk of AD. Here, MAPT is linked to Alzheimer disease.